Tag:
Dulera
Latest Headlines
Latest Headlines
Merck wins FDA approval of combo asthma therapy
The FDA has waved the green regulatory flag for Merck's new asthma drug Dulera, a two-in-one fixed-dose combo drug that is also being studied for chronic obstructive pulmonary disorder. Dulera
